-

Imedex, LLC is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

This activity has been approved for AMA PRA Category 1 Credit™.

MAINTENANCE OF CERTIFICATION (MOC)

Successful completion of this CME activity enables a participant to earn MOC points towards the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is Imedex’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC Points.

ABIM Diplomates will only have 60 days from the conclusion of the conference to claim MOC points and must be able to provide to Imedex the correct ID number, DOB (MM/DD) and name as registered at ABIM.

NURSING

This activity has been planned and implemented in accordance with the Essential Areas and policies of the American Nurses Credentialing Center (ANCC) through the joint providership of North American Center for Continuing Medical Education, LLC (NACCME), and Imedex.  The North American Center for Continuing Medical Education, LLC (NACCME) is accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE) and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.

PHARMACY

Imedex, LLC is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.

PROCESSING OF CME/CNE/CPE CERTIFICATES

After the meeting concludes, participants will be emailed a link from Imedex, LLC to receive your credit certificate or certificate of participation. We will not be issuing certificates of credit or certificates of participation onsite.

• Medical_Professionals
• Medical_students
• Nurses

Advances in Inflammatory Bowel Diseases is dedicated to the interests of the entire community of IBD patients and is designed to meet the educational needs of all healthcare professionals who treat and manage patients with inflammatory bowel diseases.

We believe the growth and success of Advances in IBD comes from our dedication to offering a comprehensive scientific agenda that is clinically relevant, scientifically state of the art, and the most effective in addressing the educational needs of attendees, while always remaining focused on the goal of enhancing the lives of patients with inflammatory bowel diseases.

HISTORICAL TIMELINE

2002: Imedex launches the Advances in Inflammatory Bowel Diseases conference in New York, New York, chaired by Dr. Richard MacDermott.

2003: The conference moves to a new location: Chicago, Illinois.

2004: Dr. Stephen Hanauer joins AIBD as Co-Chair. The conference grows to an attendance of over 300, with presentations by 24 faculty experts.

2005: AIBD heads for warmer climates, relocating to southern Florida. Under the successful leadership of the esteemed Co-Chairs and developing a world-class program, AIBD continues to grow to record numbers.

2006: For the first time, Advances in Inflammatory Bowel Diseases breaks the 500 attendee ceiling.

2008: In just two short years, AIBD doubles its attendance to over 1000.

2014: Fast forward to 2014, and AIBD, having outgrown all of the surrounding venues, relocates to Orlando, Florida. With 64 faculty experts, over 100 educational presentations and 296 abstracts, AIBD educates over 1900 attendees in its new home.

2016: Once again, Imedex's AIBD conference continues to host a record number of attendees who flock to the conference to network with their colleagues, experience cutting-edge education, and learn state-of-the-art methods for improving patient care.

Stephen B. Hanauer, MD, FACG

Northwestern University Feinberg School of Medicine

avatar for Richard P. MacDermott, MD, MACG

Richard P. MacDermott, MD, MACG

Albany Medical College

avatar for Miguel D. Regueiro, MD, FACG

Miguel D. Regueiro, MD, FACG

Cleveland Clinic

USD

Group registrations not allowed

Accompanying persons not allowed

We don’t accept Online Abstracts

WALT DISNEY WORLD

DOLPHIN HOTEL

1500 Epcot Resorts Boulevard

Lake Buena Vista, Florida 32830

Telephone: (407) 934-4000

swandolphin.com

Submission Info

We invite you to share your endeavors with the healthcare community at the 2018 Advances in Inflammatory Bowel Diseases Conference by submitting an abstract online. The submission deadline is September 11, 2018 at 11:59 PM ET.

Increase Your Prestige. Seize the opportunity to present your work at one of the most highly-regarded conferences in the field to more than 2,000+ attendees.

Gain added exposure for your work. Accepted abstracts will be published in the American Journal of Gastroenterology and scheduled for poster presentation.

Share with your colleagues. A reception in conjunction with poster viewing encourages visibility.

Receive an award or grant. A limited number of travel grants will be offered. These scholarship awards are available to assist with conference-related travel expenses by providing 1) free conference registration and 2) a scholarship of $500.

Participants interested in presenting data should submit abstracts online by September 11, 2018 at 11:59 PM ET. Abstracts are subject to acceptance by the Scientific Review Committee. Abstracts selected for presentation will be published in the American Journal of Gastroenterology and scheduled for poster presentation. Only abstracts received by the submission deadline will be published. Acceptance notifications will be sent on October 15, 2018.

Abstracts will be accepted in the following categories: CLINICAL, PEDIATRIC, or NURSING. Please indicate which category is appropriate by checking the appropriate box in the online submission system.

ABSTRACT CATEGORIES

CLINICAL ABSTRACT CATEGORIES

C1. Outcomes Research

C2. Clinical Trials and IBD Therapies

C3. Procedures and Diagnostics

C4. Case Reports

PEDIATRIC CLINICAL ABSTRACT CATEGORIES

P. Pediatrics

NURSING ABSTRACT CATEGORIES NURSING ABSTRACT CATEGORIES

N. Nurses/Advanced Practice Providers

NURSING ABSTRACT CATEGORIES NURSING ABSTRACT CATEGORIES

S. Surgery

ABSTRACT GUIDELINES

ACCEPTED FORMAT

Abstracts must be in English.

9-point Arial font

500 word count limit

Use a concise title in title case only.

List affiliations of author(s) as briefly as possible, with city, province/state, and country. The system can accommodate up to 20 total authors.

Use standard and well-accepted abbreviations.

When listing references, use standard and well-accepted formats.

Abstract content should be single-spaced and typed in lower case.

Abstracts shall be of original research and contain a concise statement of study aim.

Please include the following four (4) parts of your abstract:

Background, Methods, Results, and Conclusion(s). Conclusions must be supported by your results and summarized within your abstract at the time of submission. Results "to be completed" and/or conclusions "to be discussed" are not acceptable.

Abstract submission deadline 2018-09-11

IMEDEX CUSTOMER SERVICE

(678) 242-0906; (800) 233-0957

Fax: (678) 242-0920

meetings@imedex.com

COMMERCIAL OPPORTUNITIES & EXHIBITS

Stacy S. Brandau

Global Business Development, Commercial Sales

(404) 384-8416

s.brandau@imedex.com

IMEDEX CUSTOMER SERVICE

(678) 242-0906; (800) 233-0957

Fax: (678) 242-0920

meetings@imedex.com

COMMERCIAL OPPORTUNITIES & EXHIBITS

Stacy S. Brandau

Global Business Development, Commercial Sales

(404) 384-8416

s.brandau@imedex.com